| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |